Skip to content

Drug interactions

Bivalirudin + Imatinib

Severity: Moderate

Bivalirudin and Imatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Imatinib can cause thrombocytopenia and other cytopenias, and bivalirudin is a direct thrombin inhibitor, so combining them may raise the risk of bleeding. The effect is additive and pharmacodynamic rather than pharmacokinetic.

What this interaction means in plain words

Bivalirudin and Imatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Additive bleeding risk from imatinib-induced thrombocytopenia plus direct thrombin inhibition.

What to do

Check the platelet count before and during bivalirudin use, and monitor for bleeding signs and the ACT where it applies. Adjust anticoagulation if the platelet count falls substantially.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bivalirudin and Imatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bivalirudin with Imatinib?

MediHelp rates the interaction as moderate. Bivalirudin and Imatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Imatinib can cause thrombocytopenia and other cytopenias, and bivalirudin is a direct thrombin inhibitor, so combining them may raise the risk of bleeding. The effect is additive and pharmacodynamic rather than pharmacokinetic.

How serious is the interaction between Bivalirudin and Imatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check the platelet count before and during bivalirudin use, and monitor for bleeding signs and the ACT where it applies. Adjust anticoagulation if the platelet count falls substantially.

What other medicines interact with Imatinib?

MediHelp also lists interactions of Imatinib with, for example, Lomitapide, Lonafarnib, Amobarbital. The full list is on the Imatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in